Discurriendo por la resbaladiza frontera entre los robots enriquecidos con material biológico y los cíborgs, la labor de diversos equipos de científicos en el mundo avanza más rápidamente de lo que lo hacen los juicios morales y la legislación. El e …
Según las conclusiones a las que se ha llegado en un estudio reciente, los planetas rocosos con agua como la Tierra pueden ser muchísimo más abundantes de lo creído, al menos en nuestra galaxia. El origen del agua que en la superficie de la Tierra conforma mares …
Los planetas habitables como la Tierra quizá sean la norma en vez de la excepción Read More »
Catalent, Inc. today announced a business update.
Soligenix, Inc. announced today that the Company convened a Type A Meeting with the United States (U.S.) Food and Drug Administration.
Soligenix Provides Regulatory Update on HyBryte™ Read More »
Horizon Therapeutics plc Announces FDA Approval of an Update to the Indication Language for TEPEZZA ® (teprotumumab-trbw) to Specify its Use in Thyroid Eye Disease (TED) Patients Regardless of Disease Activity or Duration.
Phase Genomics, Inc and Element Biosciences , the developer of an innovative DNA sequencing platform disrupting genomics, today released new details of their first collaboration leveraging Phase Genomics’ proprietary OncoTerra™ cytogenomics platform and the Element AVITI System for next generation sequencing (NGS).
En este Short examinamos el curioso acto de desperezarse y sus posibles orígenes y efectos. …
Caris Life Sciences® announced that the company and partners within the Caris Precision Oncology Alliance™ will collectively present four studies across 14 tumor types at the 2023 American Association for Cancer Research Annual Meeting being held April 14-19, 2023 in Orlando, Florida, at Booth Number 130.
Immunis, Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has appointed Neil Sahota as its Chief Artificial Intelligence Officer.
Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer Read More »
Bio-Thera Solutions, Ltd. announced the company will present one poster concerning Phase 1 clinical results for BAT1006 at the 2023 American Association for Cancer Research Annual Meeting taking place April 14 – April 19, 2023 in Orlando, Florida.
